Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 3

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy

Total article views   Abstract views HTML views PDF downloads Totals
5,046 Dovepress* 5,046 0+ 1,418 5,046
Totals 5,046 0 1,418 5,046
*Since 15 July 2007
+Since July 2016

View citations on Google Scholar